BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9771940)

  • 1. Rearrangements in minisatellite sequences induced by aflatoxin B1 in a metabolically competent strain of Saccharomyces cerevisiae.
    Kaplanski C; Wild CP; Sengstag C
    Carcinogenesis; 1998 Sep; 19(9):1673-8. PubMed ID: 9771940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minisatellite rearrangements are increased in liver tumours induced by transplacental aflatoxin B1 treatment of hepatitis B virus transgenic mice, but not in spontaneously arising tumours.
    Kaplanski C; Chisari FV; Wild CP
    Carcinogenesis; 1997 Apr; 18(4):633-9. PubMed ID: 9111192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
    Sengstag C; Weibel B; Fasullo M
    Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
    Fasullo M; Smith A; Egner P; Cera C
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.
    Guo Y; Breeden LL; Zarbl H; Preston BD; Eaton DL
    Mol Cell Biol; 2005 Jul; 25(14):5823-33. PubMed ID: 15988000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Profiling for Aflatoxin B
    St John N; Freedland J; Baldino H; Doyle F; Cera C; Begley T; Fasullo M
    G3 (Bethesda); 2020 Nov; 10(11):3929-3947. PubMed ID: 32994210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.
    Fasullo M; Freedland J; St John N; Cera C; Egner P; Hartog M; Ding X
    Environ Mol Mutagen; 2017 May; 58(4):217-227. PubMed ID: 28436563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
    Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
    Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon 249 of the human TP53 tumor suppressor gene is no hot spot for aflatoxin B1 in a heterologous background.
    Sengstag C; Mörbe JL; Weibel B
    Mutat Res; 1999 Nov; 430(1):131-44. PubMed ID: 10592324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent rearrangements at minisatellite loci D1S7 (1p33-35), D7S22 (7q36-ter) and D12S11 (12q24.3-ter) in hepatitis B virus-positive hepatocellular carcinomas from Thai patients.
    Kaplanski C; Srivatanakul P; Wild CP
    Int J Cancer; 1997 Jul; 72(2):248-54. PubMed ID: 9219828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro aflatoxin B1-induced p53 mutations.
    Chan KT; Hsieh DP; Lung ML
    Cancer Lett; 2003 Sep; 199(1):1-7. PubMed ID: 12963117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line.
    Stettler PM; Sengstag C
    Mol Carcinog; 2001 Jul; 31(3):125-38. PubMed ID: 11479921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous promutagen activation in the yeast Saccharomyces cerevisiae: factors influencing aflatoxin B1 mutagenicity.
    Niggli B; Friederich U; Hann D; Würgler FE
    Mutat Res; 1986 Dec; 175(4):223-9. PubMed ID: 3097533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes.
    Sengstag C; Würgler FE
    Mol Carcinog; 1994 Dec; 11(4):227-35. PubMed ID: 7999264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compounds.
    Nixon JE; Hendricks JD; Pawlowski NE; Pereira CB; Sinnhuber RO; Bailey GS
    Carcinogenesis; 1984 May; 5(5):615-9. PubMed ID: 6426808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism.
    Gradelet S; Le Bon AM; Bergès R; Suschetet M; Astorg P
    Carcinogenesis; 1998 Mar; 19(3):403-11. PubMed ID: 9525273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different sources of Saccharomyces cerevisiae biomass on milk production, composition, and aflatoxin M
    Gonçalves BL; Gonçalves JL; Rosim RE; Cappato LP; Cruz AG; Oliveira CAF; Corassin CH
    J Dairy Sci; 2017 Jul; 100(7):5701-5708. PubMed ID: 28478008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers.
    Manson MM; Hudson EA; Ball HW; Barrett MC; Clark HL; Judah DJ; Verschoyle RD; Neal GE
    Carcinogenesis; 1998 Oct; 19(10):1829-36. PubMed ID: 9806166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
    Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
    Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.